Author(s): V. Subhahini*, Vinay Alaparthi* and B.Suresh
Journal: Journal of Pharmacy Research
ISSN 0974-6943
Volume: 4;
Issue: 9;
Start page: 3159;
Date: 2011;
Original page
Keywords: PV-pharmacovigilance | ADR - adverse-drug-reaction | PMS-post-market surveillance | PE-pharmacoeconomic | PVPE- pharmacovigilance | pharmacoeconomic.
ABSTRACT
The discipline of PV has developed considerably since 1972 WHO technical report, it remains a dynamic clinical and scientific discipline. It has been essential tomeet the challenges of the increasing range and potency of medicines (including vaccines), which carry with them an inevitable and sometimes unpredictablepotential for harm. Measures for unsafe use, negative outcomes of medication are usually used before measures of safe and effective use. Product-defect and ADRreporting systems comprise the basic elements of PV worldwide. Issues addressed in PV specification are evidence-based justification and PMS of individual drugsafety. To evaluate the outcomes of PV, PE study is one of the best tools. The rationale of drug safety can be assessed using the combination of PVPE studies.
Journal: Journal of Pharmacy Research
ISSN 0974-6943
Volume: 4;
Issue: 9;
Start page: 3159;
Date: 2011;
Original page
Keywords: PV-pharmacovigilance | ADR - adverse-drug-reaction | PMS-post-market surveillance | PE-pharmacoeconomic | PVPE- pharmacovigilance | pharmacoeconomic.
ABSTRACT
The discipline of PV has developed considerably since 1972 WHO technical report, it remains a dynamic clinical and scientific discipline. It has been essential tomeet the challenges of the increasing range and potency of medicines (including vaccines), which carry with them an inevitable and sometimes unpredictablepotential for harm. Measures for unsafe use, negative outcomes of medication are usually used before measures of safe and effective use. Product-defect and ADRreporting systems comprise the basic elements of PV worldwide. Issues addressed in PV specification are evidence-based justification and PMS of individual drugsafety. To evaluate the outcomes of PV, PE study is one of the best tools. The rationale of drug safety can be assessed using the combination of PVPE studies.
